Impact of pharmacist-led medication assessments on medication costs

Derek Jorgenson,Eric Landry,Hishaam Bhimji,Katherine Lysak

Case finding for urinary incontinence and falls in older adults at community pharmacies

Adrian Wagg,Cheryl A. Sadowski,Eric Duong,Jane Schulz,Kathleen F. Hunter,Margaret Spencer,Ross T. Tsuyuki,Yazid N. Al Hamarneh

Pharmacists should counsel users of medical cannabis, but should they be dispensing it?

Paul Grootendorst,Rajivi Ranjithan

Continuation or deprescribing of proton pump inhibitors: A consult patient decision aid

Barbara Farrell,Cynthia Way,Lisa Richardson,Lise M. Bjerre,Peter Tugwell,Vivian Welch,Wade Thompson

Cross-Canada Updates

Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study

Carlo A. Marra,Karissa Johnston,Ross T. Tsuyuki,Yazid N. Al Hamarneh

Professional abstinence: What does it mean for pharmacists?

Catherine Biggs,Jill Hall,Theresa L. Charrois

Regulation and innovation in practice – Not a “drug interaction”?

Pharmacists to improve hypertension management: Guideline concordance from North America to Europe

Arnaud Chiolero,Daniela Anker,Gilles Paradis,Ross T. Tsuyuki,Valérie Santschi

Report from the 2018 National Summit on Wicked Problems in Community Pharmacy

Andrea Bishop,Beverley Zwicker

Leadership training for pharmacists

Expansion of patient safety regulatory requirements in community pharmacy in Canada: The Melissa Sheldrick effect?

James R. Barker,Neil J. MacKinnon,Ryan Cook

Systematic review of community pharmacy–based and pharmacist-led foot care interventions for adults with type 2 diabetes

Allison L. Soprovich,Dean T. Eurich,Jeffrey A. Johnson,Lisa Tjosvold,Vishal Sharma

Major concerns remain around pay-for-performance programs in Canada

Cross-Canada updates

The evolution of pharmacy practice research—Part I: Time to implement the evidence

Adherence to tamoxifen in breast cancer patients: What role does the pharmacist play in German primary care?

Charlotte Kloft,Lea Botermann,Lena Klopp-Schulze,Madlene Schulz,Sandra Meyer,Stefanie Keilhack

Cross-Canada updates

The evolution of pharmacy practice research—Part II: Time to join the rest of the world

Lessons learned from 3 attempts to use data sources to evaluate pharmacist prescribing in Ontario

Elizabeth A. Bojarski,Lisa M. McCarthy,Lisa R. Dolovich,Nancy M. Waite

Cross-Canada updates

Community pharmacists’ experiences with the Saskatchewan Medication Assessment Program

Charity Evans,Derek Jorgenson,Jason Perepelkin,Kerry Mansell,Krysta Currie

The conference experience—Making it yours

Community-based management of epistaxis: Who bloody knows?

Jenna Smith,Jennifer Hanson,Raiyan Chowdhury,Tammy J. Bungard

The patient experience in a community pharmacy mental illness and addictions program

Andrea L. Murphy,David M. Gardner,Lisa M. Jacobs

The pharmacist’s role in successful deprescribing through hospital medication reconciliation

Ali Elbeddini,Cathy X. Y. Zhang

Medical abortion: A practice tool for pharmacists

Ashley Bancsi,Kelly Grindrod

Travelers’ diarrhea: Clinical practice guidelines for pharmacists

Ajit Johal,Heidi V. J. Fernandes,Mark S. Riddle,Sherilyn K. D. Houle

Pharmacists’ lack of profession-hood: Professional identity formation and its implications for practice

Paul Gregory,Zubin Austin

Dietary sodium and the health of Canadians

Canada’s new Healthy Eating Strategy: Implications for health care professionals and a call to action

Janusz Kaczorowski,Kim D. Raine,Manuel Arango,Nadia A. Khan,Norm R. C. Campbell,Ross T. Tsuyuki,Simon L. Bacon

Medication safety expertise at your fingertips: Medication Incident Analysis Knowledge Mobilization Tool

Certina Ho,Edmond Chiu,Roger Cheng

Qualitative exploration of the education and skill needs of community pharmacists in Saskatoon concerning substance use disorder

Anas El-Aneed,Roy Dobson,Sarah Fatani

It’s time to “Rethink Pharmacists”

Canadian guideline on HIV preexposure prophylaxis and nonoccupational postexposure prophylaxis for pharmacists

Christine Hughes,Darrell H. S. Tan,Deborah Yoong,Mark Hull,Pierre Giguère

Remunerated patient care services and injections by pharmacists: An international update

Caitlin A. Carter,Kelly A. Grindrod,Ross T. Tsuyuki,Sherilyn K. D. Houle

Why are we limiting access to opioid agonist therapies?

Jaris Swidrovich

Evidence-based practice: Are we in or not?

David J. Edwards

Pharmacy in the 21st century: Enhancing the impact of the profession of pharmacy on people’s lives in the context of health care trends, evidence and policies

Barbara Farrell,Beth Sproule,Feng Chang,Kelly Grindrod,Lisa Dolovich,Lisa McCarthy,Lori MacCallum,Nancy Waite,Sherilyn Houle,Zubin Austin

A pharmacist framework for implementation of the Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Beth Sproule,Feng Chang,Laura Murphy,Shelita Dattani

Reply from the authors

Hiroshi Okada,Ross T. Tsuyuki,Sherilyn K. D. Houle

Pharmacists’ role in cannabis dispensing and counselling

Heather Mohr,Shelita Dattani

A leadership crisis in pharmacy

It’s time to prioritize the various roles of the pharmacist

Patients’ perceptions and use of natural health products

Arden R. Barry

Cover: June 1942

The pharmacist of tomorrow: February 1940

Pharmacist prescribing and care improves cardiovascular risk, but what do patients think? A substudy of the RxEACH study

Brenda Hemmelgarn,Charlotte A. Jones,Cliff Mitchell,Kathryn King Shier,Maoliosa Donald,Ross T. Tsuyuki,Sarah Lamb,Yazid N. Al Harmarneh

The scoop on serotonin syndrome

Ai-Leng Foong,Jamie Kellar,Kelly A. Grindrod,Tejal Patel

Impact of the Canadian Pharmacists Journal